Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 3/20 | 0.43 |
| ▸ | PDE4A | P27815 | 2/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 4/20 | 0.41 |
| ▸ | MAOA | P21397 | 4/20 | 0.41 |
| ▸ | ACHE | P22303 | 4/20 | 0.41 |
| ▸ | MAOB | P27338 | 4/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.40 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.40 |
| ▸ | STS | P08842 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2407707 | 1.00 | PDE4B (0.43) | PDE4BPDE4APDE4CPDE4DMAPT | |
| SCHEMBL16480368 | 0.88 | TP53 (0.41) | MAPTMEN1KMT2A | |
| SCHEMBL13633439 | 0.85 | GPR119 (0.49) | USP30 | |
| SCHEMBL389696 | 0.82 | GPR119 (0.48) | — | |
| SCHEMBL389697 | 0.82 | GPR119 (0.48) | — | |
| SCHEMBL2411348 | 0.81 | ALOX5 (0.42) | PDE4BMAPTSMN1; SMN2BCHEMAOA | |
| SCHEMBL2407227 | 0.80 | MAPT (0.48) | MAPTSMN1; SMN2ALOX5 | |
| SCHEMBL2407229 | 0.80 | MAPT (0.48) | MAPTSMN1; SMN2ALOX5 | |
| SCHEMBL2407869 | 0.80 | KDM4E (0.41) | MAPTSMN1; SMN2BCHEMAOAACHE | |
| SCHEMBL2407867 | 0.80 | KDM4E (0.41) | MAPTSMN1; SMN2BCHEMAOAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8629277-B2 | Styrenyl 1,2,4-oxadiazole compounds | Piramal Enterprises Limited (IN) | 2014-01-14 | — | — | US | claimed |
| US-20130005771-A1 | OXADIAZOLE COMPOUNDS, THEIR PREPARATION AND USE | Piramal Enterprises Limited (IN) | 2013-01-03 | — | — | US | claimed |
| EP-2539327-A1 | OXADIAZOLE COMPOUNDS, THEIR PREPARATION AND USE | Piramal Enterprises Limited (IN) | 2013-01-02 | — | — | EP | claimed |
| WO-2011104680-A1 | OXADIAZOLE COMPOUNDS, THEIR PREPARATION AND USE | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2011-09-01 | — | — | WO | claimed |
| US-8629277-B2 | Styrenyl 1,2,4-oxadiazole compounds | Piramal Enterprises Limited (IN) | 2014-01-14 | — | — | US | disclosed |
| US-20130005771-A1 | OXADIAZOLE COMPOUNDS, THEIR PREPARATION AND USE | Piramal Enterprises Limited (IN) | 2013-01-03 | — | — | US | disclosed |
| EP-2539327-A1 | OXADIAZOLE COMPOUNDS, THEIR PREPARATION AND USE | Piramal Enterprises Limited (IN) | 2013-01-02 | — | — | EP | disclosed |
| WO-2011104680-A1 | OXADIAZOLE COMPOUNDS, THEIR PREPARATION AND USE | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2011-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005771-A1 | OXADIAZOLE COMPOUNDS, THEIR PREPARATION AND USE | MCL1, OXA1L, ABL1 | PDE4B 824/4885PDE4A 1203/4885PDE4C 1535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.